Dare Bioscience (DARE) Invested Capital (2013 - 2026)
Dare Bioscience's (DARE) quarterly Invested Capital came in at $1.5 million in Q4 2025, up 36755.01% YoY from N/an in Q4 2024, and down 26.58% on a QoQ basis from $2.0 million in Q3 2025.
Dare Bioscience (DARE) Invested Capital (2013 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 8 years of Invested Capital data on file, last reported at $1.5 million in Q4 2025.
- Quarterly Invested Capital rose 36755.01% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (up 195413.12% YoY) and the FY2025 annual result came in at $1.5 million, up 36755.01% from the prior year.
- Invested Capital fell to $1.5 million in Q4 2025, from $2.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $2.4 million in Q1 2025 to a low of $4054.0 in Q4 2024.
- A 3-year average of $1.4 million and a median of $1.5 million in 2025 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 36755.01% in 2025, down 36755.01% in 2025.
- Tracing DARE's Invested Capital over 3 years: stood at $1.0 million in 2021, then tumbled by 99.59% to $4054.0 in 2024, then soared by 36755.01% to $1.5 million in 2025.
- The last three Invested Capital figures came in at $1.5 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 | 149,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 149,374.00 |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 4,054.00 |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Sep 30, 2020 | 1.00 Mn |
| Dec 31, 2016 | 8.38 Mn |
| Sep 30, 2016 | 8.19 Mn |
| Jun 30, 2016 | 8.02 Mn |
| Mar 31, 2016 | 7.83 Mn |
| Dec 31, 2015 | 7.65 Mn |
| Sep 30, 2015 | 4.03 Mn |
| Jun 30, 2015 | 2.65 Mn |
| Mar 31, 2015 | 836,000.00 |
| Dec 31, 2014 | 3.12 Mn |
| Sep 30, 2014 | 3.35 Mn |